Welcome, Guest
Register
Sign In
Member Center
Sign Out
Register
Sign In
Go
Symbol Lookup
Loading...
Go
HOME
NEWS
U.S.
Asia
Europe
Economy
Energy
Inside Wealth
Politics
Technology
Blogs
Slideshows
Special Reports
Corrections
MARKETS
Pre-Markets
US
Europe
Asia
Stocks
Commodities
Currencies
Bonds
Funds
ETFs
EARNINGS
Calendar
Surprises
Highlights
INVESTING
Stock Blog
Personal Finance
CNBC Explains
Portfolio
Watchlist
Stock Screener
Fund Screener
Small Business
Franchising
Financing
Management
Video
VIDEO
Latest Video
Top Video
U.S. Video
Europe Video
Asia Video
CEO Interviews
Analyst Interviews
CNBC TV
CNBC U.S.
CNBC Asia-Pacific
CNBC Europe
CNBC World
CNBC Pro
Streaming Stock Quotes Are
Teva Pharmaceutical Industries Ltd
(TEVA :
)
Real Time Stock Quote | Source:
Extended Hours
---
Last Trade
---
*
After Hours Change
---
Volume
---
After Hours
---
Last Trade
---
*
Change
---
Volume
---
Trade Time
Symbol :
Go
[Find Symbol]
QUOTE
CHART
NEWS
PROFILE
EARNINGS
PEERS
FINANCIALS
OWNERSHIP
TEVA FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
More
After-Hours Buzz: Adobe, La-Z-Boy, Teva Pharmaceuticals & More
6 hrs ago - CNBC.com
Teva Pharma buying MicroDose Therapeutx for $40M
17 Jun 2013 - The Associated Press
U.S. judge approves FDA plan to drop limits on morning after pill
12 Jun 2013 - Reuters
Dow Ends Below 15000, Logs First 3-Day Drop in 2013
12 Jun 2013 - CNBC.com
Pfizer Wins in $2.15 Billion Patent Infringement Case
12 Jun 2013 - CNBC.com
Plan-B for All-No Age Limits on Morning-After Pill
11 Jun 2013 - Reuters
Momenta Pharma rises following upgrade from UBS
06 Jun 2013 - The Associated Press
Sector Snap: Makers of morning-after pill rise
06 Jun 2013 - The Associated Press
ANALYSIS-After tech success, Israel seeks life sciences growth
06 Jun 2013 - Reuters
MORE FROM CNBC
More
After-Hours Buzz: Adobe, La-Z-Boy, Teva Pharmaceuticals & More
6 hrs ago - CNBC.com
Dow Ends Below 15000, Logs First 3-Day Drop in 2013
12 Jun 2013 - CNBC.com
Pfizer Wins in $2.15 Billion Patent Infringement Case
12 Jun 2013 - CNBC.com
PRESS RELEASES
More
Teva Strengthens Respiratory Franchise with Acquisition of MicroDose T...
17 Jun 2013 - Business Wire
Teva Announces AZILECT?? (Rasagiline Tablets) Data to Be Presented at ...
14 Jun 2013 - Business Wire
Prize4Life and Knopp Neurosciences Announce Donation of EMPOWER Phase ...
13 Jun 2013 - Business Wire
Subcutaneous, Self-Administered Methotrexate for Rheumatoid Arthritis ...
13 Jun 2013 - Business Wire
Teva to Present at the Goldman Sachs 34th Annual Global Healthcare Con...
12 Jun 2013 - Business Wire
IATI-BioMed 2013: Digital Age Revolutionizing Life Sciences
12 Jun 2013 - Business Wire
Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Ge...
12 Jun 2013 - Business Wire
Teva and Active Biotech Report Positive Results from Phase IIa Study o...
12 Jun 2013 - Business Wire
New Studies, Regulatory Submissions, and Leadership Changes - Research...
10 Jun 2013 - PR Newswire
NYSE Euronext Welcomes Leading Global Healthcare Supplier, Perrigo Com...
06 Jun 2013 - Business Wire
Markets
Economy
Companies
Top News & ANALYSIS
Dish Abandons Sprint Bid, Good News for Softbank
Even Fed May Not Be Able to Tame Volatile Trading
Google Facilitates Illegal Activity, Say State AGs
Yellen to Succeed Bernanke?
Fast Money Traders: 'Full-Speed Ahead' Before Fed
Adobe Outlook 'Pretty Impressive': Analyst
United Elite Status? Depends on How Much You Spend
Icahn Proposes Tender for 1.1 Billion Dell Shares
NYSE Bomb Plot Foiled by Surveillance Program: FBI
Home Builders Slow New Construction, Raise Prices
SPECIAL OFFER
Download Free Annual Report.